Is Drixoral Still Available, and What to Use Instead?

Drixoral, the cold and allergy medication that built a devoted following over several decades, is no longer manufactured or sold in the United States or Canada. The product quietly disappeared from pharmacy shelves around 2007–2008, and despite persistent consumer demand and online petitions, its manufacturer has never resumed production. The reasons behind the disappearance involve a mix of regulatory pressure on pseudoephedrine-containing products and manufacturing decisions that the company has never fully explained publicly. For the many people who relied on Drixoral and still search for it years later, the practical question is what comes closest to replacing it.

What Drixoral Was and Why People Loved It

Drixoral Cold & Allergy was a sustained-release tablet combining two active ingredients: dexbrompheniramine maleate (6 mg) and pseudoephedrine sulfate (120 mg), dosed every 12 hours.¹ Dexbrompheniramine is a first-generation antihistamine, meaning it crosses into the brain and blocks not only histamine receptors but also muscarinic (acetylcholine) receptors. That dual action made it effective against runny nose, sneezing, and postnasal drip in a way that newer antihistamines often are not. Pseudoephedrine, the decongestant half, shrank swollen nasal passages and opened up breathing.

The combination hit a sweet spot for cold sufferers and allergy patients alike. First-generation antihistamines reduce sneezing, nasal mucus output, and sometimes cough during colds, while second-generation antihistamines have not been effective for the same complaints in clinical trials.² That difference explains why so many cold sufferers found Drixoral more effective than products built around newer antihistamines like loratadine or cetirizine. The sustained-release format also meant you took one tablet in the morning and one at night, avoiding the every-four-hours dosing of many first-generation antihistamines.

Why It Disappeared

The most commonly cited factor is pseudoephedrine regulation. In 2006, the Combat Methamphetamine Epidemic Act amended the Controlled Substances Act to place strict controls on the sale of pseudoephedrine, ephedrine, and phenylpropanolamine because they can serve as precursor chemicals for illicit methamphetamine manufacturing.³ The law moved pseudoephedrine products behind the pharmacy counter, imposed purchase limits, and required buyers to show identification and sign a log. For manufacturers, this regulatory overhead added cost and complexity. Many pseudoephedrine products were reformulated with phenylephrine to stay on open shelves, while others were simply discontinued.

Schering-Plough, Drixoral’s maker (later absorbed into Merck through a merger), never gave a definitive public explanation for pulling the product. Industry observers have noted that the company faced manufacturing problems at its facility around the same time and that production of Drixoral never resumed after those issues were resolved. Whatever the full story, the result was the same: a product vanished with no direct replacement announced, leaving a gap that consumers have been trying to fill ever since.

Why Simply Reformulating With Phenylephrine Would Not Work

When pseudoephedrine regulation tightened, many brands switched to phenylephrine as their oral decongestant. That swap looked convenient on paper but created a real efficacy problem. Phenylephrine taken by mouth is heavily broken down in the gut before it ever reaches the bloodstream, and its effectiveness as a nasal decongestant is not supported by clinical evidence the way pseudoephedrine’s is.⁴ In 2023, an FDA advisory panel voted unanimously that oral phenylephrine at standard doses is no better than a placebo for nasal congestion, and the FDA subsequently proposed revoking its status as an effective decongestant.

This matters for anyone looking at Drixoral substitutes. Any over-the-counter cold product listing phenylephrine as its decongestant is unlikely to replicate Drixoral’s congestion relief. You need a product containing pseudoephedrine, which means going to the pharmacy counter and showing ID, but getting a decongestant that actually works.

The Closest Over-the-Counter Matches

No single product on the market today replicates Drixoral’s exact formula. The dexbrompheniramine-plus-pseudoephedrine combination is not currently sold by any major brand in the United States. However, you can get reasonably close by looking at the two halves of Drixoral separately and finding products that cover each one.

Brompheniramine Plus Pseudoephedrine

The nearest relative to dexbrompheniramine is brompheniramine, the racemic version of the same molecule. Several store-brand and generic cold products still combine brompheniramine with pseudoephedrine, typically as a liquid or an immediate-release tablet. The dosing interval is shorter than Drixoral’s 12-hour sustained-release format, which means more frequent dosing and potentially more fluctuation in symptom control throughout the day. Still, the pharmacological profile is very similar, and this is the combination that most closely mirrors what Drixoral did.

Chlorpheniramine Plus Pseudoephedrine

Chlorpheniramine is another first-generation antihistamine in the same chemical family as dexbrompheniramine, and it shares many of the same properties, including blocking both histamine and muscarinic receptors and crossing into the brain. Products combining chlorpheniramine with pseudoephedrine are widely available behind the pharmacy counter. They are often marketed for cold and flu rather than allergies, but the mechanism is the same. Like brompheniramine, chlorpheniramine causes drowsiness, which is the main trade-off of first-generation antihistamines.

Second-Generation Antihistamine Plus Pseudoephedrine

If you primarily need allergy relief rather than cold symptom control, a combination of loratadine and pseudoephedrine (sold as Claritin-D and generics) or cetirizine and pseudoephedrine (sold as Zyrtec-D and generics) offers the convenience of once- or twice-daily dosing with a non-sedating antihistamine. Clinical trials have shown that loratadine-pseudoephedrine relieves nasal congestion effectively in seasonal allergic rhinitis.⁵ Both once-daily and twice-daily formulations of loratadine-pseudoephedrine perform comparably.⁶

The caveat is that second-generation antihistamines are less effective against the full range of cold symptoms. They block histamine receptors without crossing into the brain and without much muscarinic activity, which means they are weaker at drying up a runny nose from a viral infection.² For pure allergies, though, the pseudoephedrine component still handles the congestion, and the non-drowsy antihistamine handles the itching, sneezing, and watery eyes without putting you to sleep.

When You Are Treating a Cold Versus Allergies

The choice of replacement depends heavily on what you are actually treating. If your main complaint is a cold, the first-generation antihistamines are the better match for what Drixoral did. Their ability to cross the blood-brain barrier and block muscarinic receptors is precisely what makes them effective against the sneezing, mucus production, and drip of a viral upper respiratory infection. The drowsiness that comes along for the ride is the main downside, but taking a dose at bedtime and letting the sedation work in your favor is a common strategy.

If your main complaint is seasonal or perennial allergies, you have more flexibility. The allergic response is driven by histamine more directly than a cold is, so second-generation antihistamines like loratadine, cetirizine, and fexofenadine handle the sneezing and itching quite well without sedation. Pair one of those with behind-the-counter pseudoephedrine for congestion, and you have a reasonable allergy regimen, even though it does not come in the single convenient tablet Drixoral offered.

Intranasal Steroid Sprays as an Alternative Approach

For chronic nasal congestion driven by allergies, intranasal corticosteroid sprays like fluticasone (Flonase) and triamcinolide (Nasacort) have become the first-line recommendation in most allergy treatment guidelines. These sprays reduce inflammation directly in the nasal tissue and tackle congestion, sneezing, and runny nose all at once. They are now available over the counter and are generally well tolerated for long-term use, unlike oral decongestants, which are best used for short stretches.

An older trial comparing an oral antihistamine-decongestant combination with beclomethasone nasal spray found them broadly comparable for nasal symptoms, though the oral combination provided better relief from eye symptoms.⁷ For many allergy patients, using a nasal steroid spray daily and keeping an oral antihistamine on hand for breakthrough symptoms offers steadier control than any oral combination pill, including the old Drixoral.

What About Nasal Decongestant Sprays

Topical nasal decongestant sprays such as oxymetazoline (Afrin) and xylometazoline work faster and more powerfully than any oral decongestant. They constrict blood vessels directly in the nasal lining and can open up breathing within minutes. When used as directed, they are considered safe.⁸ The well-known risk is rebound congestion: using them beyond the recommended three to five days can lead to worsening swelling that drives you to spray more, creating a cycle called rhinitis medicamentosa. One short study of ten days’ use found no rebound swelling after treatment ended, suggesting that moderate overuse may not always trigger the problem.⁹ But the risk is real enough that most experts recommend keeping topical decongestants as a short-term rescue tool rather than a daily habit.

For someone who relied on Drixoral during acute colds lasting a week or less, a topical decongestant spray combined with an oral first-generation antihistamine can cover similar ground. You get fast nasal relief from the spray and systemic antihistamine effects from the pill, without needing an oral decongestant at all.

Saline Irrigation as a Drug-Free Complement

Nasal saline irrigation is not a replacement for Drixoral, but it is worth knowing about as something you can add to whatever oral medication you choose. High-volume, low-pressure saline rinses physically flush out allergens, infectious agents, and inflammatory debris from the nasal passages.¹⁰ A meta-analysis found that hypertonic saline irrigation reduced nasal symptom scores in both adults and children with allergic rhinitis and lowered the amount of antihistamine medication people needed.¹¹ Using a neti pot or squeeze bottle once or twice daily, especially during allergy season or when you have a cold, can reduce the burden you are asking your medication to handle.

Blood Pressure and Heart Rate Concerns With Pseudoephedrine

One reason some people have moved away from pseudoephedrine-based products is concern about cardiovascular effects. Pseudoephedrine is a stimulant, and it does have a measurable effect on blood pressure and heart rate. A meta-analysis of clinical trials found that in people with known, stable, treated high blood pressure, pseudoephedrine raised systolic blood pressure by a modest average of about 1.2 mmHg and heart rate by less than one beat per minute.¹² Those changes are small, but they are not zero, and individual responses vary. If you have uncontrolled hypertension or heart disease, talk to your doctor or pharmacist before reaching for any pseudoephedrine product.

This was true of Drixoral too, of course. The pseudoephedrine dose in Drixoral Cold & Allergy was 120 mg per tablet, taken twice daily, for a total daily pseudoephedrine dose of 240 mg. Any replacement containing pseudoephedrine at similar doses carries the same cardiovascular profile.

Safety in Older Adults and Children

Two populations deserve special caution when considering Drixoral-type products. For adults 65 and older, the American Geriatrics Society’s Beers Criteria lists first-generation antihistamines among the potentially inappropriate medications that are typically best avoided.¹³ The anticholinergic effects that make these drugs effective against runny noses and sneezing also cause side effects that older adults are more sensitive to: confusion, dizziness, dry mouth, urinary retention, and increased fall risk. If you are over 65 and miss Drixoral, a second-generation antihistamine paired with pseudoephedrine or a nasal steroid spray is a safer starting point.

For children, the FDA does not recommend cough and cold products containing antihistamines or decongestants in children under two years old, and evidence on safety and efficacy in children under six is thin.¹⁴ Drixoral was never marketed for very young children, but parents looking for pediatric alternatives should stick with saline irrigation, a cool-mist humidifier, and age-appropriate doses of single-ingredient medications only after checking with a pediatrician.

Compounding Pharmacies and Online Claims

Searching online for Drixoral today leads to a mix of frustration and questionable offerings. Some websites claim to sell Drixoral or “equivalent” formulations, often at inflated prices. Be skeptical. The original manufactured product has been off the market for well over a decade, and any tablets still floating around would be long past their expiration date. Expired medications lose potency and can degrade into compounds you do not want to ingest.

A more legitimate option is a compounding pharmacy. These pharmacies can legally prepare a custom combination of dexbrompheniramine and pseudoephedrine in capsule form with a doctor’s prescription. The result is pharmacologically identical to what Drixoral contained, though the sustained-release matrix technology of the original tablet is difficult to replicate in a compounding setting. You may end up with a shorter-acting preparation that requires more frequent dosing. Compounded medications are also not covered by most insurance plans and tend to cost more per dose than mass-manufactured products.

A Dexbrompheniramine Detail Worth Knowing

Research has uncovered an interesting property of dexbrompheniramine beyond its antihistamine and anticholinergic effects. In laboratory studies, dexbrompheniramine inhibited a pain-related receptor called TRPV1, which responds to capsaicin and is involved in airway irritation. Chlorpheniramine showed a similar effect, but diphenhydramine (Benadryl) and fexofenadine (Allegra) did not.¹⁵ This may partly explain why some people felt Drixoral soothed irritated airways in a way that other antihistamines did not, though this finding comes from cell and animal studies, not human trials. Whether it translates into a clinically meaningful difference in cough or throat irritation is still unknown, but it gives a pharmacological reason to suspect that not all first-generation antihistamines are interchangeable in how they feel to the user.

If this TRPV1 effect matters to you in practice, chlorpheniramine would be the closest substitute, since it showed the same receptor activity in the same experiments. Chlorpheniramine is inexpensive, widely available, and can be bought alongside pseudoephedrine at the pharmacy counter to approximate Drixoral’s two-pronged approach.